These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18853394)

  • 1. Characterization of impurities in sisomicin and netilmicin by liquid chromatography/mass spectrometry.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3455-71. PubMed ID: 18853394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of impurities in tobramycin by liquid chromatography-mass spectrometry.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    J Chromatogr A; 2009 May; 1216(18):3941-5. PubMed ID: 19321172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of unknown related substances in commercial neomycin samples with liquid chromatography/ion trap tandem mass spectrometry.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(11):1791-8. PubMed ID: 17486672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of dihydrostreptomycin-related substances by liquid chromatography coupled to ion trap mass spectrometry.
    Pendela M; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2009 Jun; 23(12):1856-62. PubMed ID: 19449319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry.
    Grahek R; Zupancic-Kralj L
    J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric characterization of gentamicin components separated by the new European Pharmacopoeia method.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2011 Apr; 55(1):78-84. PubMed ID: 21316176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of impurities in josamycin using dual liquid chromatography combined with mass spectrometry.
    Van den Bossche L; Daidone F; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jan; 73():66-76. PubMed ID: 22326844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
    Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
    Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of impurities in dirithromycin by liquid chromatography/ion trap mass spectrometry.
    Diana J; Govaerts C; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2006 Aug; 1125(1):52-66. PubMed ID: 16782117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of unknown compounds in gentamicin bulk samples with liquid chromatography coupled with ion trap mass spectrometry.
    Li B; Adams E; Van Schepdael A; Hoogmartens J
    Rapid Commun Mass Spectrom; 2006; 20(3):393-402. PubMed ID: 16381062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention pattern profiling of fungal metabolites on mixed-mode reversed-phase/weak anion exchange stationary phases in comparison to reversed-phase and weak anion exchange separation materials by liquid chromatography-electrospray ionisation-tandem mass spectrometry.
    Apfelthaler E; Bicker W; Lämmerhofer M; Sulyok M; Krska R; Lindner W; Schuhmacher R
    J Chromatogr A; 2008 May; 1191(1-2):171-81. PubMed ID: 18199445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved liquid chromatographic method with pulsed electrochemical detection for the analysis of gentamicin.
    Manyanga V; Kreft K; Divjak B; Hoogmartens J; Adams E
    J Chromatogr A; 2008 May; 1189(1-2):347-54. PubMed ID: 18199440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of impurities in vertilmicin sulfate by liquid chromatography ion-trap mass spectrometry.
    Yuan YZ; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jun; 80():1-8. PubMed ID: 23518304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry.
    Debremaeker D; Visky D; Chepkwony HK; Van Schepdael A; Roets E; Hoogmartens J
    Rapid Commun Mass Spectrom; 2003; 17(4):342-50. PubMed ID: 12569445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of vancomycin and related substances by liquid chromatography/ion trap mass spectrometry.
    Diana J; Visky D; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2006; 20(4):685-93. PubMed ID: 16447148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of polypeptide antibiotics of the polymyxin series by liquid chromatography electrospray ionization ion trap tandem mass spectrometry.
    Govaerts C; Orwa J; Van Schepdael A; Roets E; Hoogmartens J
    J Pept Sci; 2002 Feb; 8(2):45-55. PubMed ID: 11860028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a liquid chromatography-ultraviolet method with a non-volatile eluent, peak trapping and a liquid chromatography-mass spectrometry method with a volatile eluent to characterise erythromycin related substances.
    Pendela M; Van den Bossche L; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2008 Feb; 1180(1-2):108-21. PubMed ID: 18177878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of impurities in tylosin using dual liquid chromatography combined with ion trap mass spectrometry.
    Chopra S; Van Schepdael A; Hoogmartens J; Adams E
    Talanta; 2013 Mar; 106():29-38. PubMed ID: 23598092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of unknown related substances in commercial erythromycin samples with liquid chromatography/mass spectrometry.
    Govaerts C; Chepkwony HK; Schepdael AV; Roets E; Hoogmartens J
    Rapid Commun Mass Spectrom; 2000; 14(10):878-84. PubMed ID: 10825252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.